SMILES codes of virtual hits obtained in the natural products database virtual screening (only from plants selected for in vitro hERG screening).
Virtual hits from Carapichea ipecacuanha

Emetine (1) CC[C@@H]1CN2CCC3=C(C=C(OC)C(OC)=C3)[C@@H]2C[C@@H]1C[C@H]1NCCC2=C1C=C(OC)C(OC)=C2 Cephaeline (2) CC[C@@H]1CN2CCC3=C(C=C(OC)C(OC)=C3)[C@H]2C[C@H]1C[C@@H]1NCCC2=C1C=C(OC)C(O)=C2 Psychotrine (3) [H][C@@]12C[C@H](CC3=NCCC4=C3C=C(OC)C(O)=C4)[C@@H](CC)CN1CCC1=C2C=C(OC)C(OC)=C1 O-methylpsychotrine (4) CC[C@H]1CN2CCC3=C(C=C(OC)C(OC)=C3)[C@@H]2C[C@@H]1CC1=NCCC2=C1C=C(OC)C(OC)=C2 N-methylemetine (5) [H][C@]1(C[C@H]2C[C@]3([H])N(CCC4=C3C=C(OC)C(OC)=C4)C[C@@H]2CC)N(C)CCC2=C1C=C(OC)C(OC)=C2 Emetamine (6) CC[C@H]1CN2CCC3=C(C=C(OC)C(OC)=C3)[C@@H]2C[C@@H]1CC1=C2C=C(OC)C(OC)=CC2=CC=N1
Virtual hits from Cinchona sp.
COC1=CC2=C(NC([C@H]3C[C@H]4CCN3C[C@@H]4C=C)=C2C[C@H]2NCCC3=C2NC2=C3C=C(OC)C=C2)C=C 1 COC1=CC2=C(NC3=C2CCN2C[C@H](C=C)[C@H](CC4=C5NC6=C(C=C(OC)C=C6)C5=CC=N4)C[C@H]32)C=C1 COC1=CC2=C(NC3=C2CCN[C@@H]3C[C@@H]2C[C@H]3N(CCC4=C3NC3=C4C=C(OC
Virtual hits from Claviceps purpurea
Virtual hits from Coffea sp.
Virtual hits from Glycine max Virtual hits from Lobelia sp.
Virtual hits from Nelumbo nucifera
Virtual hits from Rauwolfia sp.
Virtual hits from Strychnos sp.
Virtual hits from Uncaria sp.
COC(=O)C1=CN2CCC3=C(NC4=CC=CC=C34)[C@@]2(C)[C@H]2CN3CCC4=C(NC5=CC=CC=C45)[C@H]3C[C@ @H]12 CC[C@@H]1CN2CCC3=C(NC4=CC=CC(O)=C34)[C@H]2C[C@H]1\C(=C/OC)C(=O)OC CO\C=C(/[C@H]1C[C@H]2N(CCC3=C2NC2=CC=CC(O)=C32)C[C@H]1C=C)C(=O)OC CC[C@H]1CN2CCC3=C(NC4=CC=CC(O)=C34)[C@H]2C[C@H]1\C(=C\OC)C(=O)OC COC(=O)C1=CO[C@@H](C)[C@@H]2CN3CC[C@]4(NC5=C(C=CC=C5)C4=O)[C@@H]3C[C@H]12 COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@@H](O)[C@@H](O)[C@H]2O)[C@H](C=C)[C@@H]1C[C@ H]1N[C@H](CC2=C1NC1=CC=CC=C21)C(O)=O
Virtual hits from Ziziphus sp.
CC[C@@H](C)[C@H](NC(=O)[C@@H](CC(C)C)N(C)C)C(=O)N1CC[C@H]2OC3=CC=C(C=C3)\C=C/NC(=O)[C@H] (CC3=CC=CC=C3)NC(=O)[C@H]12 CC(C)C[C@@H]1N(C)CN([C@@H]2[C@H](OC3=CC=C(C=C3)\C=C/NC(=O)[C@@H](CC(C)C)NC2=O)C2=CC=CC =C2)C1=O CC(C)[C@H](NC(=O)[C@@H](C)N(C)C)C(=O)N1CC[C@H]2OC3=CC=C(C=C3)\C=C/NC(=O)[C@@H](NC(=O)[C@ H]12)[C@@H](O)C1=CC=CC=C1 CC(C)C[C@H]1NC(=O)[C@H]2[C@@H](CCN2C(=O)[C@@H](CC2=CNC3=C2C=CC=C3)N(C)C)OC2=CC=C(C=C2 )\C=C/NC1=O CC(C)C[C@H]1NC(=O)[C@H](NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)N(C)C)[C@H](OC2=CC=C(C=C2)\C=C/ NC1=O)C(C)C CC[C@@H](C)[C@H](NC)C(=O)N1CC[C@@H]2OC3=CC=C(C=C3)\C=C/NC(=O)[C@H](CC3=CC=CC=C3)NC(=O) [C@H]12 CC[C@H](C)[C@@H]1NC(=O)[C@H](NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)N(C)C)[C@H](OC2=CC=C(C=C 2)\C=C/NC1=O)C(C)C COC1=C2C=CC(O[C@H]3CCN([C@H]3C(=O)N[C@H](CC3=CC=CC=C3)C(=O)N\C=C/2)C(=O)[C@@H](NC(=O)[C @@H](C)N(C)C)C(C)C)=C1 CN[C@@H](C(C)C)C(=O)N1CC[C@@H]2OC3=CC=C(C=C3)\C=C/NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H] 12 CC[C@H](C)[C@@H]1NC(=O)[C@H]2[C@H](CCN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CC=CC=C2)N(C)C) OC2=CC(\C=C/NC1=O)=C(O)C=C2 CC[C@H](C)[C@@H]1NC(=O)[C@@H]2[C@@H](CCN2C(=O)[C@@H](CC(C)C)N(C)C)OC2=CC(\C=C/NC1=O)=C (OC)C=C2 CC[C@H](C)[C@H](N(C)C)C(=O)N[C@H](CC(C)C)C(=O)N1CC[C@H]2OC3=CC(\C=C/NC(=O)[C@H]4CCCN4C(= O)[C@H]12)=C(OC)C=C3 CC(C)C[C@H](NC(=O)[C@H](C)N(C)C)C(=O)N1CC[C@@H]2OC3=CC=C(C=C3)\C=C/NC(=O)[C@@H](CC3=CC= CC=C3)NC(=O)[C@H]12
Full experimental details on hERG electrophysiology studies
Initial hERG block screening in oocytes: Preparation of stage V-VI Xenopus laevis (NASCO)
oocytes, synthesis of complementary RNA (cRNA) transcripts from linearized complementary DNA (cDNA) templates (NP000229, kindly provided by Dr. Sanguinetti, University of Utah), and injection of cRNA were performed as described previously [1] . Currents through hERG channels were studied 1-3 days after cRNA microinjection by a two-microelectrode voltageclamp technique using a TURBO TEC-03X amplifier (npi electronic GmbH). The extracellular solution (pH 7.4) contained (in mM) 96 NaCl, 2 KCl, 1 MgCl 2 × 6 H 2 O, 1.8 CaCl 2 × 2 H 2 O, and 5 HEPES (Sigma-Aldrich GmbH). Voltage-recording and current-injecting microelectrodes (Harvard Apparatus) were filled with 3 M KCl and showed resistances between 0.5-2 MΩ. pClamp v.10.0 (Molecular Devices, Inc.) was used for data acquisition.
The following voltage protocol was applied in 1 s intervals (frequency: 1 Hz): from a holding potential of -80 mV, the cell membrane was depolarized to +20 mV (300 ms) to achieve channel activation and subsequent rapid inactivation. Following repolarization to -50 mV (300 ms), channels recovered from inactivation and elicited the typical hERG current (I hERG ). A final step returning to the initial holding potential ensured channels returned to the closed state. Oocytes presenting endogenous currents above 0.2 μA or maximal current amplitudes above 3 µA were disregarded.
Samples were freshly diluted in extracellular solution and applied to oocytes via a fast perfusion technique (ScreeningTool, npi electronic GmbH), as previously described [2] . Thioridazine hydrochloride (30 μM, ≥ 99% purity, Sigma-Aldrich GmbH) was used as a positive control. Data were analyzed using Origin software 7.0 (OriginLab Corporation) and expressed as the percentage of hERG tail current block. Each data point represents the mean ± SD (n = 3-5) from at least two independent oocyte batches. ATP-Mg 2+ , 3 phosphocreatine-Na 2 -H 2 O, 9 sucrose; and osmolality at 295 ± 5 mOsmol/L.
The following pulse protocol was applied in 10 s intervals (frequency: 0.1 Hz): cells were clamped to -80 mV (200 ms) and then shifted to -50 mV (200 ms) to determine the leak current of the cell. Thereafter, cells were depolarized for 2 s at +40 mV and back to -50 mV for 2 s to hERG tail current activation. At the end of the pulse protocol, cells were clamped again to holding potential. Experiments were conducted at room temperature, and membrane resistance (R m ) was continuously monitored. Recordings below 500 MΩ without recovery were stopped and repeated.
Samples were freshly diluted in extracellular solution yielding the correct compound concentration in 0.1% DMSO. Cisapride (100 nM, ≥ 98% purity, Sigma-Aldrich GmbH) was used as a positive control. When a stable whole-cell recording configuration was established, the cell was initially perfused with extracellular buffer to reach stable recordings, and thereafter up to three increasing concentrations of the same sample were applied for 5 min each to the same cell.
hERG tail current amplitudes were monitored and the amplitude was calculated by subtraction of the leak current from the maximal current peak amplitude during the tail phase. The mean current
